Updated Review of Clinicaltrials.gov
Compared to GLP-1, the second residue of exenatide is Gly rather than Ala
In 2023, Juan P Frias and colleagues, in The Lancet, published the first phase two clinical trial of orforglipron, which investigated the use of a small-molecule oral GLP-1R agonist called orforglipron in type 2 diabetes, which can be taken at any time of the day without restrictions on food and water intake (Frias et al., 2023)
Rapid or significant weight loss can leave you with loose skin, so its difficult to maintain that tight appearance
GLP-1 Medications Pros: Non-surgical Effective weight loss for many patients May improve blood sugar levels Cons: Often require lifelong use Can cost $900$1,500 per month Weight regain is common after stopping Long-term effects are still being studied Bariatric Surgery Bariatric surgery procedures such as gastric sleeve or gastric bypass offer a different approach
J Pharm Sci